Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.

@article{Libby2018InflammationIA,
  title={Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.},
  author={Peter Libby and Joseph Loscalzo and Paul M. Ridker and Michael E. Farkouh and Priscilla Y. Hsue and Valentin Fuster and Ahmed Abdallah Hasan and Salomon Amar},
  journal={Journal of the American College of Cardiology},
  year={2018},
  volume={72 17},
  pages={
          2071-2081
        }
}
Observations on human and experimental atherosclerosis, biomarker studies, and now a large-scale clinical trial support the operation of immune and inflammatory pathways in this disease. The factors that incite innate and adaptive immune responses implicated in atherogenesis and in lesion complication include traditional risk factors such as protein and lipid components of native and modified low-density lipoprotein, angiotensin II, smoking, visceral adipose tissue, and dysmetabolism… CONTINUE READING
63
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 112 REFERENCES

Pathogen recognition and inflammatory signaling in innate immune defenses.

  • Clinical microbiology reviews
  • 2009
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Colchicine Cardiovascular Outcomes Trial (COLCOT). 2017

Tardif J-C, P L’Allier
  • Available at: https://clinicaltrials.gov/ct2/show/NCT02551094. Accessed August
  • 2018